The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a nonprofit organization with the purposes of

  • Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
  • Communicating accurate legal educational information; and
  • Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

ASPL has become the premier source to engage with the entire spectrum of professionals at the intersection of pharmacy and legal matters. With my formal training, I approach our meetings with the assumption that I have grasped all of the components that contribute to the pharmacy profession. However, engaging with ASPL has placed context around the various, often overlooked, downstream and upstream factors that impact the law as it applies to pharmacy.
Monet Stanford, PharmD

Latest News

October 14,  2019

CONTROLLED SUBSTANCES

DEA implements single-page order forms
Effective October 30, the DEA has published revisions to its rules under the Controlled Substances Act (CSA) regarding order forms for Schedule II controlled substances. The rules now specify the use of a single-page DEA Form 222, and the DEA will phase out of triplicate order forms over a 2-year period, i.e., until October 30, 2021.

Under the new rules, registrants must make and retain a copy of the completed Form 222 prior to submitting it to the wholesaler or distributor; the distributor will permanently keep the original and will indicate on the original the number of packages supplied for each line on the form. The registrant will document on its copy of the 222 the actual number of packages received. As with the triplicate forms, the single-page forms must be stored separately from all other records maintained by the registrant. The rule allows for electronic transmission of Form 222 to the supplier, and DEA will deem electronic records to be maintained separately “if such copies are readily retrievable separately from all other records. Electronic copies of DEA Forms 222 may be stored on a system at a location separate from the registered location, provided such copies are readily retrievable at the registered location.”

Effective October 30, DEA will no longer issue triplicate versions of Form 222. [USDOJ, DEA. 21 CFR Part 1305, New single-sheet format for U.S. Official Order Form for Schedule I and II Controlled Substances (DEA Form 222). 84 Fed. Reg. 51368-51377, September 30, 2019]